Ursodeoxycholyl lysophosphatidylethanolamide attenuates hepatofibrogenesis by impairment of TGF-β1/Smad2/3 signalling
Pathil, Anita, Mueller, Jan, Ludwig, Johannes M, Wang, Jiliang, Warth, Arne, Chamulitrat, Walee, Stremmel, WolfgangLanguage:
english
Journal:
British Journal of Pharmacology
DOI:
10.1111/bph.12837
Date:
October, 2014
File:
PDF, 1.73 MB
english, 2014